ORCL has broken through the $184 floor that held for two weeks, and the question is no longer whether the stock stabilises — it's whether $165 is where the selling stops.
The collapse has accelerated. The stock closed at $165.16 on June 23, down 5.7% on the day and 12.3% on the week. That pushes the one-month loss to 14%. The previous two trader notes tracked a stock pinned at $184, absorbing peer weakness through "simple durability." That durability is gone. The $184 floor broke, and the stock has now shed roughly 25% from where it traded before the June 10 earnings print. Peers have also pulled back, but the comparison no longer flatters: NOW fell 8.9% on the week, NTNX lost 5.5%, and DDOG dropped 3.7%. RBRK and bucked the move, closing up on the week. The sector is under pressure, but Oracle is still underperforming its closest correlated names.
Options traders have moved to their most defensive posture in months. The put/call ratio hit 1.02 — roughly 2.5 standard deviations above its 20-day average of 0.92. That reading is near the 52-week high of 1.06, reached during the last episode of acute stress. The demand for downside protection is running at an intensity this stock has rarely seen. The borrow market, by contrast, tells almost no story: short interest is 1.2% of the free float, borrow costs run at 0.39%, and availability is an exceptionally loose 6,534% — there are roughly 65 shares available in the lending pool for every one currently borrowed. Short sellers are not driving this decline.
The Street's conviction has not wavered, even as the market has. After the June 10 print, most analysts reaffirmed their ratings. Bernstein raised its target to $325. Barclays lifted to $250. DA Davidson moved to $225. The dissent is narrow: Wedbush, one of the louder bulls in the group, cut its target from $275 to $240 — a meaningful trim — while Scotiabank dropped from $290 to $241. Stephens holds the most cautious formal view with a $164 target, essentially in line with where the stock is now. The consensus remains a buy, and with a mean target around $260, the implied upside has now stretched to roughly 57% at current prices. The bull case rests on cloud revenue growing 41% year-on-year to $8.9 billion, a 243% AI-infrastructure demand surge, and FY27 revenue guidance of $90 billion. The bear case is that the market priced perfection, and the capex required to sustain that growth — $8.5 billion last quarter — makes near-term free cash flow a genuine concern alongside competition in database and middleware markets. EPS momentum scores remain strong, ranking in the 97th percentile on a 30-day basis and 88th on a 90-day view, but the 12-month forward EPS growth rank is only in the 31st percentile, reflecting the market's scepticism about how quickly the AI revenues convert.
The earnings history adds relevant context. The June 10 print produced a 10.5% single-session decline and a 10.8% loss over five days. The prior quarter's earnings, reported in June 2025, generated a 3.7% one-day drop and a 9.8% five-day decline. Back-to-back post-earnings selloffs of that magnitude are rare for a stock of Oracle's size and generate a consistent pattern: the stock falls, stabilises, and then faces a second wave of selling as the initial floor attracts sellers rather than buyers. That second wave appears to be what the market is now experiencing.
What to watch from here is whether the $165 zone holds on meaningful volume or whether the stock traces the same pattern it followed after each of those prior earnings dislocations — a brief consolidation followed by another leg down before any durable floor forms. The gap between the most cautious analyst target ($164, from Stephens) and the current price has effectively closed. If the stock breaks below that level, the Street's entire buy-side consensus will be underwater on a sum-of-targets basis, which historically changes the analyst revision dynamic and removes one of the floor mechanisms that has supported the stock since June 10.
See the live data behind this article on ORTEX.
Open ORCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
